
Sign up to save your podcasts
Or


In this episode of Let's Talk Medtech, AngioDynamics CEO James Clemmer shares insights into what has been a transformative year for the medical device company across multiple therapeutic areas.
Clemmer highlighted several significant achievements that have strengthened the company's position in both oncology and vascular care. He also describes how a crucial pivot helped redefine AngioDynamics.
By Informa Markets4.9
77 ratings
In this episode of Let's Talk Medtech, AngioDynamics CEO James Clemmer shares insights into what has been a transformative year for the medical device company across multiple therapeutic areas.
Clemmer highlighted several significant achievements that have strengthened the company's position in both oncology and vascular care. He also describes how a crucial pivot helped redefine AngioDynamics.

112,840 Listeners